PA

Paul Anderson

Orthocell Limited | Chief Executive Officer, Managing Director
Mr Anderson has over 20 years of experience in the medical device and regenerative medicine fields with expertise in bridging the gap between research and clinical practice in the development of emerging medical technologies. He also has expertise in the establishment of GMP manufacturing facilities and scale-up activities for cell therapies and biological medical devices, and the associated regulatory filings.

Company and Roles

Company
Title
Tenure
Since
OCC
Orthocell Limited
  • Chief Executive Officer
  • Managing Director
19yrs, 1mthMar 2006

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
OCC
Orthocell Limited
15/10/24268,1056,984,215500,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
OCC
Orthocell Limited
29/11/24
Issued
2,148,088$0.810$1,739,951Issue of securities
OCC
Orthocell Limited
15/10/24
Buy
268,089$0.730$195,704Exercise of options
OCC
Orthocell Limited
15/10/24
Buy
80,426$0.730$58,710Exercise of options
OCC
Orthocell Limited
15/10/24
Exercise
5,200,000$0.730$3,796,000Exercise of options
OCC
Orthocell Limited
07/11/23
Issued
500,000$0.385$192,500Issue of options